Zimelidine
Zimelidine
Zimelidine (/zɪˈmɛlɪdiːn/) is a selective serotonin reuptake inhibitor (SSRI) used for the treatment of depression.
Etymology
The term "Zimelidine" is derived from the chemical name Z-imidazo[1,2-a]pyridin-3-yl ethyl leidenenitrile.
Usage
Zimelidine was one of the first SSRI antidepressants to be developed and was marketed in the 1980s. It was developed by the Swedish pharmaceutical company Astra AB, now known as AstraZeneca. It was primarily used to treat depressive disorders.
Side Effects
Like other SSRIs, Zimelidine can cause a variety of side effects, including nausea, insomnia, and sexual dysfunction. In rare cases, it can cause a serious condition known as Guillain-Barré syndrome, which led to its withdrawal from the market.
Related Terms
External links
- Medical encyclopedia article on Zimelidine
- Wikipedia's article - Zimelidine
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski